CALLSAS Study: Effect of Continuous Positive Airway Pressure Treatment for Obstructive Apnea on Phone Usage Habits
NCT ID: NCT03537066
Last Updated: 2022-05-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
68 participants
INTERVENTIONAL
2018-04-10
2021-06-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of Self-efficacy as a Predictor for CPAP-compliance in a OSAS-patients French Cohort
NCT05053581
Benefits of Telemedicine in CPAP Treatment
NCT03202602
Anxiety and Depression In Patients With Obstructive Sleep Apnoea Before and After Continuous Positive Airway Pressure
NCT04104880
Evaluation of the Comfort of a Continuous Positive Airway Pressure Nasal Mask in the Treatment of OSA Syndrome
NCT04925739
Interest of Treatment of Obstructive Sleep Apnea Syndrome by Constant CPAP and Auto CPAP
NCT02749812
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary objective is to analyze the modifications in phone usage habits before and after CPAP treatment.
Secondary objectives:
* Correlation between changes in phone usage habits and evolution of sleepiness
* Correlation between changes in phone usage habits and evolution of depression scale
* Correlation between changes in phone usage habits and evolution of quality of life
* Correlation between changes in physical activity measured by phones and evolution of physical activity objectively measured by actigraphy and gait platform
* Correlation between phone usage habits and CPAP adherence
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CPAP treatment
All included OSA patients are going to be treated by CPAP
CPAP
All patients included will be treated by CPAP
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CPAP
All patients included will be treated by CPAP
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Follow-up at home by AGIR à dom
* Customers of Orange (or Sosh) for mobile and/or fixed-line telephony for at least 6 months
* Patient who signed a written consent to participate in the study
* Patient affiliated to social security
Exclusion Criteria
* Patients with disease not allowing to realize functional and locomotion tests
* Person deprived of liberty by judicial or administrative decision, person subject to a legal protection measure (patient under guardianship or curatorship)
* Patient who, in the judgment of the investigator, may not be cooperative or respectful of the obligations inherent to participation in the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Grenoble
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean-Louis PEPIN
Role: PRINCIPAL_INVESTIGATOR
CHU Grenoble Alpes
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Grenoble Alps University Hospital
Grenoble, Auvergne-Rhône-Alpes, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2017-A02540-53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.